UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007352
Receipt number R000008663
Scientific Title Phase I/II trial of carboplatin plus CPT-11 chemotherapy with accelerated hyperfractionated radiotherapy for elderly patients with limited stage small cell lung cancer (TORG0604).
Date of disclosure of the study information 2012/02/23
Last modified on 2015/09/26 09:26:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase I/II trial of carboplatin plus CPT-11 chemotherapy with accelerated hyperfractionated radiotherapy for elderly patients with limited stage small cell lung cancer (TORG0604).

Acronym

Phase I/II trial of carboplatin plus CPT-11 chemotherapy with accelerated hyperfractionated radiotherapy for elderly patients with limited stage small cell lung cancer (TORG0604).

Scientific Title

Phase I/II trial of carboplatin plus CPT-11 chemotherapy with accelerated hyperfractionated radiotherapy for elderly patients with limited stage small cell lung cancer (TORG0604).

Scientific Title:Acronym

Phase I/II trial of carboplatin plus CPT-11 chemotherapy with accelerated hyperfractionated radiotherapy for elderly patients with limited stage small cell lung cancer (TORG0604).

Region

Japan


Condition

Condition

limited stage small cell lung cancer

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To assess the safety and efficacy of carboplatin plus CPT-11 chemotherapy with accelerated hyperfractionated radiotherapy for elderly patients with limited stage small cell lung cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase I,II


Assessment

Primary outcomes

Phase I: recommended dose
Phase II:toxicity profiles, response rate, feasibility

Key secondary outcomes

overall survival
progression free survival


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

carboplatin plus CPT-11 chemotherapy with accelerated hyperfractionated chestradiotherapy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

70 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) histopathologically or cytologically confirmed small cell lung cancer
2) 70 years old or more
3) limited stage small cell lung cancer
4) no prior radiotherapy or chemotherapy for the small cell lung cancer
5) Eastern Cooperative Oncology Group Performance Status:0-2
6) measurable disease
7) no other active malignancy
8) adequate organ functions: WBC> 3000/mm3, absolute neutrophil count> 1500/mm3, platelet count> 100000/mm3, hemoglobin> 9g/dL, AST< 2.5*the upper limit of normal(ULN), ALT< 2.5*ULN, bilirubin> 2.0mg/dL, serum creatinine< 1.5mg/dL, creatinine clearance> 40mL/min, PaO2> 70Torr
9) appropriate informed consent form has confirmed before registration

Key exclusion criteria

1) other active malignancy
2) active infection
3) obviously proven interstitial lund disease by x-ray
4) myocardiac infarction within six monthes before registration
5) uncontrollable heart diseases or hepatic diseeases or diabates or hemorrhage
6) severe mental disorder
7) diarrhea or watery stool
8) massive pleural effusion (more than one centimeter thickness of chest CT scan)
9) ileus

Target sample size

41


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroaki Okamoto

Organization

Yokohama Municipal Citizens' Hospital

Division name

Department of respilatory medicine and clinical oncology

Zip code


Address

56 Okazawa-cho, Hodogaya Ward, Yokohama, Kanagawa prefecture, Japan

TEL

045-331-1961

Email



Public contact

Name of contact person

1st name
Middle name
Last name Yuki Misumi

Organization

Yokohama Municipal Citizens' Hospital

Division name

Department of respilatory medicine

Zip code


Address


TEL

045-331-1961

Homepage URL


Email



Sponsor or person

Institute

Thoracic Oncology Research Group (TORG)

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 02 Month 23 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2006 Year 05 Month 12 Day

Date of IRB


Anticipated trial start date

2006 Year 12 Month 01 Day

Last follow-up date

2013 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 02 Month 21 Day

Last modified on

2015 Year 09 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008663


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name